Owning a genome

Should a large company be able to own a genome. Some large companies have genetically engineered organisms so that they are beneficial in some way (plants resistant to disease, microorganisms that clean up oil spills, etc.) should they have exclusive rights to these organisms and be able to sell them at a premium to those who need/desire them? What kind of consequences does this type of "ownership" have?